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Abstract
Seasonal influenza (flu) is an acute viral disease that occurs every winter in Germany and is referred to as the ‘flu 
wave’. The Standing Committee on Vaccination (STIKO) at the Robert Koch Institute recommends annual vaccination 
for people who are at greater risk of disease-related complications, this includes men and women aged 60 or above. 
In this target group, 48.1% of women and 48.7% of men who participated in the GEDA 2014/2015-EHIS study 
reported that they had been vaccinated against influenza during the 2013/2014 winter season. However, there were 
marked differences according to region. Vaccination rates decreased over time. Moreover, although the European 
Commission has been calling for a vaccination rate of at least 75% among the elderly from the 2014/2015 influenza 
season onwards, it is unclear to what extent this rate can actually be achieved. However, rates can be improved by 
doctors providing advice and recommending vaccination to their patients.
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Introduction
Seasonal influenza (flu) is an acute viral disease that 
affects the population of the northern hemisphere almost 
every winter. It occurs as a cluster that lasts for a num-
ber of weeks and is referred to as a ‘flu wave’. Influenza 
is typically characterised by the sudden onset of illness 
with a high fever, dry cough and pain in the muscles, 
neck and/or limbs [1]. Depending on the particular virus 
strain and a person’s level of immunity, a large propor-
tion of people with an infection may only suffer mild 
symptoms and in many cases the disease may even occur 
without any recognisable symptoms [2]. On average, an 
influenza infection lasts between five and seven days, 
but it can persist for longer, especially when combined 
with certain risk factors. Severe cases frequently result 
in lung complications such as pulmonary infections [1, 3]. 
It is important to differentiate between colds, which are 
often referred to as ‘influenza-like illnesses’, and sea-
sonal influenza. Colds result in much milder symptoms 
than influenza and are caused by different pathogens. 
Whereas influenza is triggered by influenza viruses, colds 
are caused by more than 30 different pathogens, includ-
ing RSV, rhinovirus and coronaviruses. In contrast, sea-
sonal influenza results from viruses such as Influenza 
A(H3N2), Influenza A(H1N1)pdm09 and Influenza B. 
Importantly, different virus strains are predominant in 
different years and the strength of each flu wave can vary 
considerably. According to calculations by the Robert 
Koch Institute’s Influenza Working Group (AGI), between 
one and five million influenza-related visits are made to 
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doctors annually; in years with a severe flu wave this fig-
ure can be significantly higher (see also the focus article 
on respiratory diseases in issue 3/2017 of the Journal of 
Health Monitoring). When severe flu waves do occur, as 
was the case with the 2012/2013 winter season, approx-
imately 30,000 influenza-related hospital admissions 
and 20,000 deaths can be linked to influenza. In con-
trast, the flu wave that occurred during the 2013/2014 
winter season was considered comparatively mild: it led 
to just 3,000 extra hospital admissions and no increase 
in mortality [4, 5].
Since influenza viruses are constantly changing, a 
single vaccination is not enough to prevent the disease. 
Influenza vaccination is aimed at preventing influenza 
infections, influenza-related complications and possible 
deaths. The Standing Committee on Vaccination (STIKO) 
at the Robert Koch Institute (RKI), therefore, recom-
mends that people with a higher risk of disease-related 
complications are vaccinated annually against the influ-
enza viruses in current circulation. Vaccination is par-
ticularly important for people aged 60 or above, for peo-
ple with chronic diseases, women in the second or third 
trimester of pregnancy or when an underlying disease 
that has been present since the beginning of pregnancy 
causes increased health risks, and for people who are at 
a higher risk of disease due to occupational exposure, 
such as medical staff [6]. In this latter case, vaccination 
not only protects medical professionals, it also protects 
their patients. The considerable disease burden associ-
ated with influenza has led the European Commission 
to strive for an influenza vaccination rate of at least 75% 
among the elderly from 2014/2015 onwards [7].
Indicator
In the GEDA 2014/2015-EHIS study, data on the uptake 
of influenza vaccination during the 2013/2014 winter 
season was gathered using a self-reporting questionnaire 
that the respondents completed on paper or online. The 
respondents were asked ‘Were you vaccinated against 
flu in the run-up to the 2013/2014 winter season?’ The 
recall period ranged from 8 to 23 months depending on 
when the questionnaire was completed.
The analyses undertaken for the GEDA study are based 
on information gathered from 23,339 participants aged 
18 or over (12,815 women; 10,524 men) with valid infor-
mation on the uptake of flu vaccination for the 2013/2014 
winter season. The calculations were carried out with a 
weighting factor that corrects the sample for deviations 
from the population structure in Germany (as of 31 Decem-
ber 2014) with regard to gender, age, type of municipality 
and education. ‘Municipality type’ refers to the degree of 
urbanisation in a particular area and corresponds to the 
regional distribution in Germany. The International Stand-
ard Classification of Education (ISCED) was used to clas-
sify the participants’ educational and occupational qual-
ifications [8]. A statistically significant difference between 
groups is assumed to have been demonstrated when 95% 
confidence intervals do not overlap.
A detailed description of the methodology used for 
GEDA 2014/2015-EHIS can be found in Lange et al. 2017 
[9] as well as in the article German Health Update: New 
data for Germany and Europe in issue 1/2017 of the Jour-
nal of Health Monitoring.
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims: To provide reliable informa tion 
about the population’s health status, 
health-related behaviour and health care  
in Germany, with the possibility of a  
European comparison 
Method: Questionnaires completed on 
paper or online
Population: People aged 18 years and above 
with permanent residency in Germany
Sampling: Registry office sample; randomly 
selected individuals from 301 communities 
in Germany were invited to participate
Participants: 24,016 people (13,144 women; 
10,872 men)
Response rate: 26.9%
Study period: November 2014 - July 2015
Data protection: This study was undertaken 
in strict accordance with the data protection 
regulations set out in the German Federal 
Data Protection Act and was approved by 
the German Federal Commissioner for Data 
Protection and Freedom of Information.  
Participation in the study was voluntary. 
The participants were fully informed about 
the study’s aims and content, and about 
data protection. All participants provided 
written informed consent.
 
More information in German is available at 
www.geda-studie.de
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ducted in 2009, 2010 and 2012, vaccination rates among 
people aged 60 or above declined from 57% in 2008/2009 
to 48% in the winter season of 2013/2014 [10]. This 
reduction is also very clear from accounting data held 
by the Associations of Statutory Health Insurance Phy-
sicians (KV) [11]. Moreover, the annual vaccination rate 
among people aged 60 or over (of under 50%) identified 
in these studies remains significantly lower than the rate 
recommended by the European Commission (75%) [7], 
without any indication of increased influenza vaccina-
tion uptake [10, 11].
There are clear regional differences in the uptake of 
influenza vaccination. Among people aged 60 or above 
Results and discussion
25% of participants aged 18 or above reported that they 
been vaccinated against flu for the 2013/2014 winter sea-
son; the rates for women (25.6%) and men (24.5%) were 
very similar. Despite the fact that around 75% of people 
aged 60 or above need to be vaccinated annually, 48.1% 
of women and 48.7% of men in this age group reported 
that they had been vaccinated against flu in the 2013/2014 
winter season. No association between vaccination and 
educational status were identified (Table 1).
The influenza vaccination rate among people aged 60 
or above (the target group) has decreased in recent years. 
Compared with the results of the GEDA studies con-
Table 1 
The rate of vaccination against seasonal 
influenza (flu) in the 2013/2014 winter season 
by gender, age and educational status 
(n=12,815 women; n=10,524 men) 
Source: GEDA 2014/2015-EHIS
Women % (95% CI)
Women (total) 25.6 (24.3-26.9)
18-29 Years 9.5 (8.0-11.3)
Low education 10.7 (7.2-15.6)
Medium education  9.4 (7.7-11.5)
High education 7.0 (4.8-10.2)
30-44 Years 11.6 (10.2-13.3)
Low education 7.3 (4.5-11.7)
Medium education  12.1 (10.2-14.4)
High education 13.0 (10.7-15.8)
45-59 Years 19.4 (17.8-21.2)
Low education 20.6 (16.5-25.4)
Medium education  18.8 (16.9-20.9)
High education 20.4 (17.8-23.3)
≥60 Years 48.1 (45.8-50.4)
Low education 51.1 (47.5-54.6)
Medium education  46.4 (43.4-49.5)
High education 46.0 (41.8-50.3)
Total (women and men) 25.0 (24.0-26.1)
CI=confidence interval
Men % (95% CI)
Men (total) 24.5 (23.3-25.7)
18-29 Years 9.9 (8.2-12.0)
Low education 16.4 (11.9-22.1)
Medium education  7.7 (6.0-9.9)
High education 7.9 (5.2-11.8)
30-44 Years 11.7 (10.3-13.4)
Low education 9.9 (6.1-15.8)
Medium education  12.1 (10.0-14.5)
High education 11.5 (9.4-14.0)
45-59 Years 19.7 (17.9-21.7)
Low education 19.9 (15.2-25.5)
Medium education  20.2 (17.8-22.9)
High education 18.7 (16.2-21.4)
≥60 Years 48.7 (46.6-50.8)
Low education 46.5 (41.5-51.7)
Medium education  50.5 (47.4-53.7)
High education 46.4 (43.4-49.4)
Total (women and men) 25.0 (24.0-26.1)
Less than 50% of people 
aged 60 or over are vacci-
nated against influenza.
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mern. In contrast, the federal states with the lowest vac-
cination rates are located in the extreme south (Bavaria) 
and the extreme north (Schleswig-Holstein), with rates 
of 38.4% and 39.8% respectively (Figure 1). The account-
ing data held by the KV show that regional differences 
in influenza vaccination rates are not only limited to the 
federal state level, but even occur at the district level. In 
the highest rates are found in the new German federal 
states (as was the case in previous years). This further 
demonstrates the greater acceptance of vaccination in 
the new federal states [13]. Among the target group aged 
60 or above, the highest rates of vaccination during the 
2013/2014 influenza season were achieved in Branden-
burg, Saxony-Anhalt, Saxony and Mecklenburg-Vorpom-
The vaccination rate of 75% 
among the elderly, which the 
European Commission has 
been striving for since the 
2014/2015 influenza season, 
has yet to be achieved.
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i
Figure 1 
The rate of vaccination against seasonal 
influenza (flu) in the 2013/2014 winter 
season in women and men aged 60 
or above, by federal state 
(n=1,706 women; n=1,743 men) 
Source: GEDA 2014/2015-EHIS
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be opposed to influenza vaccination in principle. In Ger-
many as well as in other countries, doctors play an 
important role in the decisions leading to vaccination 
[14, 18, 19]. However, a 2009 survey of doctors’ practices 
demonstrates that doctors do not necessary encourage 
all particularly vulnerable groups to ensure that they are 
vaccinated against influenza [20]. At the same time, Influ-
enza vaccination rates among medical staff are also still 
low in Germany and vary between 26% and 73% [20, 21] 
depending on the survey and the influenza season in 
question. The results presented here demonstrate the 
great opportunity that exists to increase the annual influ-
enza vaccination rate among the elderly. Target group-spe-
cific measures aimed at medical professionals who are 
responsible for vaccination could be a useful means of 
doing so. This would involve raising awareness about 
this issue, ensuring that it forms part of (further) train-
ing, increasing payments for vaccination and related 
consultations, and making billing processes more sim-
ple. Finally, more effort should be made to stress the 
importance of influenza vaccination among people aged 
60 or above and to increase vaccination rates. This could 
include introducing a statutory responsibility to recall 
patients for vaccination as part of active patient care, 
bonuses, and providing information about the benefits 
of vaccination to individuals and society as a whole, and 
about the serious complications that can be caused by 
vaccine-preventable diseases.
fact, these data demonstrate extreme differences at the 
district level with vaccination rates in 2013/2014 ranging 
from between 13.5% and 65% [12].
The GEDA and KV data show broadly consistent 
results with regard to changes in vaccination rates over 
time as well as in terms of the differences between fed-
eral states. However, the estimated 48% vaccination rate 
identified among the elderly in the 2013/2014 influenza 
season by the GEDA study is significantly higher than 
the rate calculated from the accounting data (38%) [11, 
12]. A telephone-based study identified a rate of 49.4% 
(95% confidence interval 44.6-54.2) for the 2013/2014 
influenza season, which is similar to the result from 
GEDA 2014/2015-EHIS [14]. Two factors may have con-
tributed to the higher rates identified by these studies: 
people who are less health conscious may also be less 
willing to participate in health studies, and respondents 
may tend to provide socially desirable answers to stud-
ies based on questionnaires and interviews.
There are important reasons why people do not 
ensure that they are vaccinated against influenza. First, 
flu is not always viewed as a serious illness that poses a 
danger to health; at the same time, people are some-
times doubtful about the safety and efficacy of vaccina-
tion. However, people do not always reject vaccination 
outright; rather, they sometimes forget to arrange an 
appointment for vaccination or do not do so for other 
reasons [14-17]. The GEDA 2014/2015-EHIS study demon-
strates that only about a quarter of people aged 60 or 
over have never been vaccinated against influenza; as 
such, a large proportion of the people who were not vac-
cinated against flu during the 2013/2014 season may not 
Flu vaccination coverage is 
very different depending on 
the region in question.
Medical advice, including 
recommendations by doctors 
to vaccinate, is an important 
way of increasing vaccination 
rates.
Journal of Health Monitoring
Journal of Health Monitoring 2017 2(4)
The uptake of influenza vaccination for the 2013/2014 season in Germany
67
FACT SHEET
13. Poethko-Müller C, Schmitz R (2013) Impfstatus von Erwachsenen 
in Deutschland. Ergebnisse der Studie zur Gesundheit 
Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl 
Gesundheitsforsch Gesundheitsschutz 56(5-6):845-857 
http://edoc.rki.de/oa/articles/reb7vPK7TXrvs/PDF/28zSzw-
wnYZBs.pdf (As at: 24.08.2017)
14. Bödeker B, Remschmidt C, Schmich P et al. (2015) Why are older 
adults and individuals with underlying chronic diseases in Ger-
many not vaccinated against flu? A population-based study. BMC 
Public Health 15:618
15 Holm MV, Blank PR, Szucs TD (2007) Trends in influenza vacci-
nation coverage rates in Germany over five seasons from 2001 to 
2006. BMC Infect Dis 7:144
16. Schmid P, Rauber D, Betsch C et al. (2017) Barriers of Influenza 
Vaccination Intention and Behavior - A Systematic Review of 
Influenza Vaccine Hesitancy, 2005 - 2016. PLoS One 
12(1):e0170550
17. Böhmer MM, Walter D, Krause G et al. (2011) Determinants of 
tetanus and seasonal influenza vaccine uptake in adults living in 
Germany. Hum Vaccin 7(12):1317-1325
18. Boes L, Boedeker B, Schmich P et al. (2017) Factors associated 
with parental acceptance of seasonal influenza vaccination for 
their children - A telephone survey in the adult population in Ger-
many. Vaccine 35(30):3789-3796
19. Blank PR, Schwenkglenks M, Szucs TD (2008) Influenza vaccina-
tion coverage rates in five European countries during season 
2006/07 and trends over six consecutive seasons. BMC Public 
Health 8:272
20. Wortberg S, Walter D, Knesebeck M et al. (2009) Niedergelassene 
Ärzte als Multiplikatoren der Influenzaimpfung bei älteren Men-
schen, chronisch Kranken und medizinischem Personal. Ergeb-
nisse einer bundesweiten Repräsentativbefragung im Rahmen 
der nationalen Influenza-Impfkampagne. Bundesgesundheitsbl 
Gesundheitsforsch Gesundheitsschutz 52(10):945-952
21. Böhmer MM, Walter D, Falkenhorst G et al. (2012) Barriers to 
pandemic influenza vaccination and uptake of seasonal influenza 
vaccine in the post-pandemic season in Germany. BMC Public 
Health2012; 12:938
References
1. Mandell GL, Bennett JE, Dolin R (2010) Principles and Practice of 
Infectious Diseases. Churchill Livingstone Philadelphia
2. Leung NH, Xu C, Ip DK et al. (2015) Review Article: The Fraction 
of Influenza Virus Infections That Are Asymptomatic: A System-
atic Review and Meta-analysis. Epidemiology 26(6):862-872
3. Remschmidt C, Harder T, Wichmann O et al. (2016) Hinter-
grundpapier der STIKO: Evaluation der bestehenden Influen-
zaimpfempfehlung für Indikationsgruppen und für Senioren 
(Standardimpfung ab 60 Jahren). Bundesgesundheitsbl Gesund-
heitsforsch Gesundheitsschutz 59(12):1606-1622 
4. Arbeitsgemeinschaft Influenza (2014) Bericht zur Epidemiologie 
der Influenza in Deutschland Saison 2013/14. RKI, Berlin 
5. Arbeitsgemeinschaft Influenza (2016) Bericht zur Epidemiologie 
der Influenza in Deutschland Saison 2015/16. RKI, Berlin 
6. Ständige Impfkommission (2013) Empfehlungen der Ständigen 
Impfkommission (STIKO) am Robert Koch-Institut/Stand: 
August 2013. Epidemiol Bull 34:313-335
7. Council of the European Union (2009) Council Recommendation 
of 22 December 2009 on seasonal influenza vaccination 
(2009/1019/EU). Off J Eur Union p. 71-2. 
8. Statistical Office of the European Union (Eurostat) (2016) Inter-
national Standard Classification of Education (ISCED)  
http://ec.europa.eu/eurostat/statistics-explained/index.php/
International_Standard_Classification_of_Education_(ISCED) 
(As at 04.12.2017) 
9. Lange C, Finger JD, Allen J et al. (2017) Implementation of the 
European health interview survey (EHIS) into the German health 
update (GEDA). Archives of Public Health 75(1):40 
10. Bödeker B, Remschmidt C, Müters S et al (2015) Impfquoten 
unter Erwachsenen in Deutschland für die Impfungen gegen sai-
sonale Influenza, Tetanus und Pertussis  Bundesgesundheitsbl 
Gesundheitsforsch Gesundheitsschutz 58 (2):174-181
11. Rieck T, Feig M, Wichmann O et al. (2017) Impfquoten der Rota-
virus-, Masern-, HPV- und Influenza- Impfung in Deutschland. 
Epidemiol Bull 1: 1-12. 
12. versorgungsatlas.de (2015) Grippe: Sinkflug der Impfraten in 
Deutschland gestoppt - Handlungsbedarf vor allem in den alten 
Bundesländern  
http://www.versorgungsatlas.de/fileadmin/pdf/15-11-03-PM_
INFLUENZA-final.pdf (As at: 24.08.2017)
Journal of Health Monitoring
Journal of Health Monitoring 2017 2(4)




This work is licensed under a 
Creative Commons Attribution 4.0 
International License.
The Robert Koch Institute is a Federal Institute within  






Susanne Bartig, Johanna Gutsche, Dr Franziska Prütz,  
Martina Rabenberg, Alexander Rommel, Dr Anke-Christine Saß, 
Stefanie Seeling, Martin Thißen, Dr Thomas Ziese
Robert Koch Institute
Department of Epidemiology and Health Monitoring
General-Pape-Str. 62–66
D-12101 Berlin




Gisela Dugnus, Alexander Krönke, Kerstin Möllerke
Translation
Simon Phillips/Tim Jack
Please cite this publication as 
Poethko-Müller C, Bödeker B (2017) The uptake of influenza  
vaccination for the 2013/2014 season in Germany. Journal of Health 
Monitoring 2(4):62–68. DOI 10.17886/RKI-GBE-2017-124
ISSN 2511-2708
Journal of Health Monitoring
Author details
Robert Koch Institute









The authors declared no conflicts of interest. 
Funding
The GEDA study was funded by the Robert Koch Institute and the 
German Federal Ministry of Health.
Note  
External contributions do not necessarily reflect the opinions of the 
Robert Koch Institute.
